Graham Cohen

1PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 12, 2024
Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study.

Graham Cohen, Bernardo Rapoport, Sze W Chan

Pageof 1

Frequent Collaborators

1 joint publications

Bernardo Rapoport

1 joint publications

Sze W Chan